371 related articles for article (PubMed ID: 25531119)
1. Individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium.
Gonzalez-Parra E; Gonzalez-Casaus ML; Arenas MD; Sainz-Prestel V; Gonzalez-Espinoza L; Muñoz-Rodriguez MA; Tabikh A; Egido J; Ortiz A
Blood Purif; 2014; 38(3-4):224-33. PubMed ID: 25531119
[TBL] [Abstract][Full Text] [Related]
2. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
[TBL] [Abstract][Full Text] [Related]
3. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
Alayoud A; El Kabbaj D; Benyahia M; Asseraji M; Zemraoui N
Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
[TBL] [Abstract][Full Text] [Related]
4. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
5. Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial.
Basile C; Libutti P; Di Turo AL; Vernaglione L; Casucci F; Losurdo N; Teutonico A; Lomonte C
Am J Kidney Dis; 2012 Jan; 59(1):92-101. PubMed ID: 22000728
[TBL] [Abstract][Full Text] [Related]
6. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.
Brunelli SM; Sibbel S; Do TP; Cooper K; Bradbury BD
Am J Kidney Dis; 2015 Oct; 66(4):655-65. PubMed ID: 26015274
[TBL] [Abstract][Full Text] [Related]
7. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism.
Fernández E; Borràs M; Pais B; Montoliu J
J Am Soc Nephrol; 1995 Jul; 6(1):132-5. PubMed ID: 7579066
[TBL] [Abstract][Full Text] [Related]
8. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
Teruel JL; Nitvarro JF; Marcen R; Aguilera A; Tato A; Ottuño J
Miner Electrolyte Metab; 1997; 23(1):19-24. PubMed ID: 9058365
[TBL] [Abstract][Full Text] [Related]
9. The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
Ando R; Naito S; Inagaki Y; Hata T; Ishida Y; Chida Y; Takayama M; Tachibana K; Ohtsuka M; Inoue A
Ther Apher Dial; 2005 Feb; 9(1):16-23. PubMed ID: 15828901
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
[TBL] [Abstract][Full Text] [Related]
11. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
Felsenfeld AJ; Ross D; Rodriguez M
J Am Soc Nephrol; 1991 Dec; 2(6):1136-43. PubMed ID: 1777594
[TBL] [Abstract][Full Text] [Related]
12. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
Heaf JG; Løkkegård H
J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
[TBL] [Abstract][Full Text] [Related]
14. [Effects of reduced dialysate calcium on mineral metabolism in hemodialysis patients].
Fujimori A; Yorifuji M; Sakai M; Fukagawa M
Clin Calcium; 2005 Sep; 15 Suppl 1():121-4; discussion 124. PubMed ID: 16272643
[TBL] [Abstract][Full Text] [Related]
15. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
16. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
Izumi M; Shirai K; Ito K; Miyamoto T; Matsumoto A; Takenaka Y; Nakagawa K; Yamanashi T; Takamitsu Y; Nakanish T
Ther Apher Dial; 2005 Feb; 9(1):24-31. PubMed ID: 15828902
[TBL] [Abstract][Full Text] [Related]
17. Should dialysate calcium be individualized?
Messa P; Sherman RA
Semin Dial; 2014; 27(1):4-7. PubMed ID: 24400799
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
[TBL] [Abstract][Full Text] [Related]
19. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients.
Saha H; Pietilä K; Mustonen J; Pasternack A; Mörsky P
Clin Nephrol; 1992 Sep; 38(3):145-8. PubMed ID: 1395167
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.
Sakai Y; Otsuka T; Ohno D; Murasawa T; Sakai S; Tsuruoka S
Ther Apher Dial; 2014 Apr; 18(2):181-4. PubMed ID: 24720409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
